CEACAM5 and adenocarcinoma: Interestingly, in patients with adenocarcinoma we observed a positive association between CEA or CYFRA21-1 reduction ≥ 20% and longer PFS whereas in patients with lung squamous carcinoma a CYFRA21-1 reduction ≥ 20% was statistically associated with better PFS.